ArticleOncotarget2018

IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line.

Haruka Furuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.